INFLECTION MEDICINE

Owners

Goods & Services

diagnostic tests consisting primarily of buffers and reagents for detecting genetic diseases and disorders

Development of diagnostic apparatus and testing kits for genetic diseases and disorders; development of technology to improve clinical outcomes of individuals with genetic diseases and disorders; development of diagnostic apparatus for identifying genetic diseases and disorders; genome sequencing services in the nature of laboratory research; clinical research in the field of rapid whole genome sequencing test to enable the prevention, diagnosis and treatment of genetic diseases and disorders; development of technology that provides clinical guidance; platform as a service (PAAS) featuring computer software platform for data analysis, data management, data storage, data interpretation, and report generation, all in the field of genetics and genetic testing; clinical decision support technology in the nature of the provision of on-line non-downloadable software to assist in the translation of complex genomic sequencing for use in treatment plans by healthcare providers; providing genetic science information

medical diagnostic and treatment services, namely, whole genome sequencing testing for treating of genetic disease and disorders; providing medical screening for detecting genetic diseases in newborns; medical diagnosis, namely, translations of complex genomic sequencing for use in individualized patient treatment plans by healthcare providers for the diagnosis and treatment of genetically-linked diseases and conditions; providing genetic counseling and providing information about genetic counseling; providing information about genetic testing for medical purposes

New product commercialization of diagnostic products for genetic diseases and disorders; new product commercialization services of technology to improve clinical outcomes of individuals with genetic diseases and disorders; new product commercialization services of diagnostic products for identifying genetic diseases and disorders; new product commercialization services of technology that provides clinical guidance